Skip to main content

Want a detailed portfolio tracker?

BioNexus Gene Lab (BGLC) Free Cash Flow (2018 - 2026)

BioNexus Gene Lab (BGLC) free cash flow from Mar 31, 2018 to Mar 31, 2026. The TTM BioNexus Gene Lab (BGLC) free cash flow is -$1.20M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Free Cash Flow

Quarterly Free Cash Flow

BioNexus Gene Lab (BGLC) Free Cash Flow CAGR table

PeriodCAGR
1 Year TTM-61.41%
3 Years TTM+393.24%

Annual Free Cash Flow change of BioNexus Gene Lab (BGLC)

YearFree Cash FlowChange
2026-$150K-92.02%
2025-$1.88M-18.97%
2024-$2.32M+78.46%
2023-$1.30M-365.31%
2022$490K+4800.00%
2021$10K-92.31%
2020$130K-156.52%
2019-$230K-25.81%
2018-$310KN/A

Comparison BioNexus Gene Lab (BGLC) five years free cash flow CAGR with competitors

BioNexus Gene Lab (BGLC) five years free cash flow CAGR is 42.49%.

TickerNamefive years Free Cash Flow CAGRUpside
KOPKoppers Holdings Inc63.31%+49.00%
YMATJ-Star Holding Co Ltd - Class A53.10%+24.96%
HWKNHawkins Inc30.21%-28.90%
ODCOil-Dri Corp Of America28.86%-32.08%
LWLGLightwave Logic Inc27.12%-36.17%
NEUNewMarket Corp22.50%-47.04%
CBTCabot Corp18.61%-56.20%
BCPCBalchem Corp10.20%-76.01%
GEVOGevo Inc7.73%-81.80%
ECLEcolab Inc6.68%-84.27%
CNEYCN Energy Group Inc - Class A4.47%-89.47%
ASHAshland Inc3.96%-90.67%
AVNTAvient Corp3.96%-90.68%
NGVTIngevity Corp3.07%-92.78%
AMTXAemetis Inc1.33%-96.86%
AXTAAxalta Coating Systems Ltd1.25%-97.05%
SHWSherwin-Williams Company0.57%-98.66%